API 0.74% $1.35 australian pharmaceutical industries limited

nice run for the last few days, page-2

  1. 2,105 Posts.
    lightbulb Created with Sketch. 41
    Market Cap for API $124m compared with SIP $846. Since the sell of of Sigma's other assets to Aspen they are now two very comparable business entities. Be interesting to compare the two companies market share of turover, profit, dividend and balance sheets for a full or half year comparison It will tell us if API is undervalued! Personally I think they are both undervalued from a long term perspective.

    Despite the hicups API has had with the loss of Pfizer prescription products (so did Sigma) Qld flooding of warehouse nad some account issues etc I believe everything is on track for a solid report on Oct 27th. Market certainly reflected this with some heavy trafic last week.

    On the whole I think API's "consistency & transparency" across their customer accounts will not have done them any harm in the longer term.
 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.